Medicaid/SCHIP: Prescription Drugs - Kaiser Family Foundation

Sort Documents by:

Document Type:

Date Range:

Medicaid/SCHIP: Prescription Drugs

Resources on Dual Eligibles and Issues Related to Their Transition to the New Medicare Drug Benefit
A collection of information and publications on dual eligibles, their current drug coverage, and issues related to their transition to the new Medicare drug benefit.

State Medicaid Outpatient Prescription Drug Policies: Findings from a National Survey, 2005 Update
This survey of state Medicaid pharmacy programs supplements surveys conducted in 2003 and 2000 and reports Medicaid prescription drug policies in effect in early 2005. It covers key elements of utilization management, drug purchasing and potential impacts of the implementation of the Medicare prescription drug benefit.

Recent Documents: (96 results)

Pages 1 | 2 | 3 | 4 | 5

Headed for a Crunch: An Update on Medicaid Spending, Coverage and Policy Heading into an Economic Downturn -- September 2008

This eighth annual 50-state survey on Medicaid and state budget actions finds enrollment began to rise in fiscal year 2008 with states expecting even larger increases for fiscal year 2009. With the increased enrollment, Medicaid spending is also rising more rapidly than in the recent past.

Kaiser Fast Facts -- May 2008
“Kaiser Fast Facts” features “QuickTakes” and “Kaiser Slides” – two tools that provide direct access to facts, data and slides about the nation's health care system and programs, in an easy-to-use format. “QuickTakes” presents an inventory of facts-at-a-glance and "Kaiser Slides" allows Web visitors to freely view, download and print graphics and tables of health policy statistics and trends.

Additional Findings from the National Surveys of Doctors and Pharmacists -- November 2006
The Kaiser Family Foundation released additional findings on a wide range of health care issues from separate national surveys of doctors and pharmacists.

Observations on the Initial Implementation of the Medicare Prescription Drug Program: Perspectives of State Medicaid Directors Through a Focus Group Discussion -- May 2006

This report summarizes the observations of Medicaid directors at a March 2006 focus group on the new Medicare drug benefit and its interactions with state Medicaid programs as dual enrollees are transition from a Medicaid drug benefit to the Medicare benefit.

Transitions 2006 -- May 2006

This 2006 video produced by the Foundation reports on the experiences of three dual enrollees as they transition from a Medicaid prescription drug benefit to the new Medicare drug benefit.

The Stability of Medicaid Coverage for Low-Income Dually Eligible Medicare Beneficiaries -- May 2006
This report examines the stability of dual eligibility for the seven million Americans who rely on Medicaid to fill the gaps in their Medicare coverage and its implications for Medicare's new prescription drug benefits. The study finds that dual-eligible beneficiaries generally remain eligible for Medicaid over time

An Update on the Clawback: Revised Health Spending Data Change State Financial Obligations for the New Medicare Drug Benefit -- March 2006

States are obligated to finance part of the new Medicare prescription drug benefit via a monthly "clawback" payment to the federal government. This issue update analyzes the latest data and provides an overview of the state financing of the Medicare drug benefit.

The Transition of Dual Eligibles to Medicare Part D Prescription Drug Coverage: State Actions During Implementation -- February 2006

This report summarizes findings from a 50-state survey of Medicaid officials to assess states’ early experience relating to the transition of dual eligibles to the Medicare Part D drug benefit. The survey covers the types of problems observed by states during the transition of dual eligibles to the Medicare drug benefit, state actions to correct problems and ensure temporary coverage, and specific data on costs incurred by states from these temporary programs.

Tracking Prescription Drug Coverage Under Medicare: Five Ways to Look at the New Enrollment Numbers -- February 2006
This issue brief examines five approaches to looking at the latest enrollment numbers for the new Medicare drug benefit and discusses each approach in terms of how it portrays the reach of the new program.

Kaiser Health Poll Report Survey – Selected Findings on Seniors' Views of the Medicare Prescription Drug Benefit -- February 2006
A February 2006 tracking poll finds that 45% of seniors say they have enrolled or plan to enroll in a drug plan, 29% say they do not intend to enroll in a drug plan and another 23% say they are uncertain. The majority of those who do not plan to enroll say they have another program or plan that helps pay for their prescriptions.

“Kaiser Fast Facts” features “QuickTakes” and “Kaiser Slides” – two tools that provide direct access to facts, data and slides about the nation's health care system and programs, in an easy-to-use format. “QuickTakes” presents an inventory of facts-at-a-glance and "Kaiser Slides" allows Web visitors to freely view, download and print graphics and tables of health policy statistics and trends.

The Kaiser Family Foundation released additional findings on a wide range of health care issues from separate national surveys of doctors and pharmacists.

This 2006 video produced by the Foundation reports on the experiences of three dual enrollees as they transition from a Medicaid prescription drug benefit to the new Medicare drug benefit.

This report examines the stability of dual eligibility for the seven million Americans who rely on Medicaid to fill the gaps in their Medicare coverage and its implications for Medicare's new prescription drug benefits. The study finds that dual-eligible beneficiaries generally remain eligible for Medicaid over time

This issue brief examines five approaches to looking at the latest enrollment numbers for the new Medicare drug benefit and discusses each approach in terms of how it portrays the reach of the new program.

A February 2006 tracking poll finds that 45% of seniors say they have enrolled or plan to enroll in a drug plan, 29% say they do not intend to enroll in a drug plan and another 23% say they are uncertain. The majority of those who do not plan to enroll say they have another program or plan that helps pay for their prescriptions.

View all items >

Pages 1 | 2 | 3 | 4 | 5

Medicaid/SCHIP: Prescription Drugs

Medicaid is currently the largest public payor for prescription drugs, and it is an important source of drug coverage for the low-income elderly, including nearly 6 million Medicare beneficiaries, and people with disabilities. While constituting roughly a quarter of Medicaid enrollment, these two populations account for approximately 80% of the program’s drug spending. Prescription drugs have been an important driver of Medicaid spending growth for the last several years, prompting heightened state efforts to control drug utilization and costs. However, the greater need for prescription drugs and financial vulnerability found within the Medicaid population means that efforts to control spending must be balanced against maintaining beneficiaries’ access to needed therapies.